Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Mădălina Bostan"'
Pushing the Limits of Medical Management in HCM: A Review of Current Pharmacological Therapy Options
Autor:
Cristian Stătescu, Ștefana Enachi, Carina Ureche, Laura Țăpoi, Larisa Anghel, Delia Șalaru, Carmen Pleșoianu, Mădălina Bostan, Dragoș Marcu, Mircea Ovanez Balasanian, Radu Andy Sascău
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 13, p 7218 (2021)
Hypertrophic cardiomyopathy (HCM) is the most common monogenic cardiac disease with a highly variable phenotypic expression, ranging from asymptomatic to drug refractory heart failure (HF) presentation. Pharmacological therapy is the first line of tr
Externí odkaz:
https://doaj.org/article/739585ed49314d5ab274f1a344f8f418
Autor:
Radu Sascău, Larisa Anghel, Alexandra Clement, Mădălina Bostan, Rodica Radu, Cristian Stătescu
Publikováno v:
Diagnostics, Vol 11, Iss 2, p 256 (2021)
Infiltrative cardiomyopathies (ICMs) comprise a broad spectrum of inherited and acquired conditions (mainly amyloidosis, sarcoidosis, and hemochromatosis), where the progressive buildup of abnormal substances within the myocardium results in left ven
Externí odkaz:
https://doaj.org/article/3a47d2b49c604671b1c94a25f7ff5d32
Autor:
Larisa Anghel, Cristian Stătescu, Ionela-Lăcrămioara Șerban, Minela Aida Mărănducă, Doina Butcovan, Alexandra Clement, Mădălina Bostan, Radu Sascău
Publikováno v:
Diagnostics, Vol 10, Iss 9, p 719 (2020)
In recent years, significant advances have been made in the diagnosis and therapeutic management of hypertrophic cardiomyopathy (HCM) patients, which has led to an important improvement in their longevity and quality of life. The use of multimodality
Externí odkaz:
https://doaj.org/article/66d60a230ed147ac8cf76ff8c7a91cbc
Autor:
Florin Leuciuc, D. Mădălina Bostan
Publikováno v:
Știința și arta mișcării. 15:12
Pushing the Limits of Medical Management in HCM: A Review of Current Pharmacological Therapy Options
Autor:
Carina Ureche, Larisa Anghel, Mădălina Bostan, Carmen Elena Pleșoianu, Dragoș Marcu, Ștefana Enachi, Laura Țăpoi, Radu Sascau, Cristian Stătescu, Mircea Balasanian, Delia Lidia Șalaru
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 7218, p 7218 (2021)
International Journal of Molecular Sciences
International Journal of Molecular Sciences
Hypertrophic cardiomyopathy (HCM) is the most common monogenic cardiac disease with a highly variable phenotypic expression, ranging from asymptomatic to drug refractory heart failure (HF) presentation. Pharmacological therapy is the first line of tr
Autor:
Mădălina Bostan, Larisa Anghel, Radu Sascau, Cristian Stătescu, Rodica Radu, Alexandra Clement
Publikováno v:
Diagnostics
Diagnostics, Vol 11, Iss 256, p 256 (2021)
Diagnostics, Vol 11, Iss 256, p 256 (2021)
Infiltrative cardiomyopathies (ICMs) comprise a broad spectrum of inherited and acquired conditions (mainly amyloidosis, sarcoidosis, and hemochromatosis), where the progressive buildup of abnormal substances within the myocardium results in left ven
Autor:
Doina Butcovan, Minela Aida Maranduca, Ionela-Lăcrămioara Șerban, Larisa Anghel, Mădălina Bostan, Cristian Stătescu, Radu Sascau, Alexandra Clement
Publikováno v:
Diagnostics
Diagnostics, Vol 10, Iss 719, p 719 (2020)
Diagnostics, Vol 10, Iss 719, p 719 (2020)
In recent years, significant advances have been made in the diagnosis and therapeutic management of hypertrophic cardiomyopathy (HCM) patients, which has led to an important improvement in their longevity and quality of life. The use of multimodality